Bridget Cornell, APRN
Family · Elkhorn, NENPI 1528413523
Payments from drug & device makers
Across 173 payments — averaging $17.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$317
- AstraZeneca$311
- Amgen$302
- Johnson & Johnson$270
- Pfizer$218
- Acadia Pharmaceuticals Inc$151
- plus $1K from 27 others
What the payments were for
- Food & beverage$2,982100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 16 | $317 |
| AstraZeneca | 17 | $311 |
| Amgen | 21 | $302 |
| Johnson & Johnson(2 entities) | 12 | $270 |
| Pfizer | 15 | $218 |
| Acadia Pharmaceuticals Inc | 10 | $151 |
| Lilly USA, LLC | 10 | $145 |
| Novo Nordisk | 9 | $136 |
| Abbott | 6 | $128 |
| Boehringer Ingelheim | 7 | $106 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $92 |
| Esperion Therapeutics, Inc. | 4 | $81 |
| UCB, Inc. | 3 | $76 |
| Incyte Corporation | 3 | $70 |
| Otsuka America Pharmaceutical, Inc. | 4 | $67 |
| Actelion Pharmaceuticals US, Inc. | 3 | $55 |
| Merck | 3 | $50 |
| E.r. Squibb & Sons, L.L.C. | 3 | $45 |
| Sanofi-aventis U.S. LLC | 2 | $36 |
| Organon | 2 | $34 |
| Astellas Pharma US Inc | 2 | $33 |
| Ultragenyx Pharmaceutical Inc. | 2 | $33 |
| Lundbeck LLC | 1 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Novartis | 2 | $31 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Sun Pharmaceutical Industries Inc. | 1 | $19 |
| Philips North America LLC | 1 | $18 |
| Dexcom, Inc. | 1 | $15 |
| GSK | 1 | $15 |
| Exact Sciences | 1 | $14 |
| Corcept Therapeutics | 1 | $14 |
| Mylan Specialty L.p. | 1 | $13 |
How this compares
$2,982 in reported general payments places this provider in the 85th percentile of 809 family providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 31 | $857 |
| Fluticasone Propionate | 23 | $536 |
| Atorvastatin Calcium | 100 | $463 |
| RizatriptanRizatriptan Benzoate | 21 | $430 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 25 | $419 |
| Levothyroxine Sodium | 68 | $390 |
| Potassium Chloride | 18 | $372 |
| Metoprolol Succinate | 29 | $355 |
| Omeprazole | 32 | $334 |
| Amlodipine Besylate | 35 | $227 |
| Lisinopril | 43 | $192 |
| Metformin Hcl | 32 | $175 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 16 | $145 |
| Losartan Potassium | 23 | $141 |
| Simvastatin | 29 | $140 |
Paid to pharmacies, not to this prescriber.
Other family in Elkhorn
- Chantel CollierFriend$257K
- Stephanie SimonOmaha$157K
- Rebecca NewberryOmaha$156K
- Michelle BrtekzwienerNorfolk$59K
- Angela CraigOmaha$35K
- Laura FalconeOmaha$26K
- Ladeana SmedlundBoys Town$21K
- Brittany MatneyOmaha$14K
- Patricia TeeterWahoo$13K
- Mary MetzLincoln$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.